Jason Swoger
Jason Swoger
Assistant Professor, Department of Gastroenterology, University of Pittsburgh Medical Center
Verified email at
Cited by
Cited by
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED–ECCO consensus
A Bourreille, A Ignjatovic, L Aabakken, EV Loftus Jr, R Eliakim, ...
Endoscopy 41 (07), 618-637, 2009
Association of vitamin D level with clinical status in inflammatory bowel disease: a 5-year longitudinal study
TA Kabbani, IE Koutroubakis, RE Schoen, C Ramos-Rivers, N Shah, ...
The American journal of gastroenterology, 2016
Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study
J Swoger, J Ponsky, DM Hicks, JE Richter, TI Abelson, C Milstein, ...
Clinical Gastroenterology and Hepatology 4 (4), 433. e1, 2006
Impact of obesity on the management and clinical course of patients with inflammatory bowel disease
JL Seminerio, IE Koutroubakis, C Ramos-Rivers, JG Hashash, ...
Inflammatory bowel diseases 21 (12), 2857-2863, 2015
Correlation between symptoms and laryngeal signs in laryngopharyngeal reflux
MA Qadeer, J Swoger, C Milstein, DM Hicks, J Ponsky, JE Richter, ...
The Laryngoscope 115 (11), 1947-1952, 2005
Postoperative therapy with infliximab prevents long-term Crohn’s disease recurrence
M Regueiro, KE Kip, L Baidoo, JM Swoger, W Schraut
Clinical Gastroenterology and Hepatology 12 (9), 1494-1502. e1, 2014
Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease
B Click, CR Rivers, IE Koutroubakis, D Babichenko, AM Anderson, ...
Inflammatory bowel diseases 22 (6), 1442-1449, 2016
Persistent or recurrent anemia is associated with severe and disabling inflammatory bowel disease
IE Koutroubakis, C Ramos–Rivers, M Regueiro, E Koutroumpakis, B Click, ...
Clinical Gastroenterology and Hepatology 13 (10), 1760-1766, 2015
Cutaneous manifestations of Crohn disease
JW Hagen, JM Swoger, LM Grandinetti
Dermatologic clinics 33 (3), 417-431, 2015
Association between telephone activity and features of patients with inflammatory bowel disease
C Ramos–Rivers, M Regueiro, EJ Vargas, E Szigethy, RE Schoen, ...
Clinical Gastroenterology and Hepatology 12 (6), 986-994. e1, 2014
Silent Crohn's disease: asymptomatic patients with elevated C-reactive protein are at risk for subsequent hospitalization
B Click, EJ Vargas, AM Anderson, S Proksell, IE Koutroubakis, CR Rivers, ...
Inflammatory bowel diseases 21 (10), 2254-2261, 2015
Adalimumab for Crohn's disease in clinical practice at Mayo clinic: the first 118 patients
JM Swoger, EV Loftus, WJ Tremaine, WA Faubion, DS Pardi, SV Kane, ...
Inflammatory bowel diseases 16 (11), 1912-1921, 2010
Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease
E Koutroumpakis, C Ramos-Rivers, M Regueiro, JG Hashash, A Barrie, ...
Digestive diseases and sciences 61 (3), 865-871, 2016
Postoperative infliximab is not associated with an increase in adverse events in Crohn’s disease
M Regueiro, S El-Hachem, KE Kip, W Schraut, L Baidoo, A Watson, ...
Digestive diseases and sciences 56 (12), 3610-3615, 2011
Physician assessment of ulcerative colitis activity correlates poorly with endoscopic disease activity
M Regueiro, J Rodemann, KE Kip, M Saul, J Swoger, L Baidoo, ...
Inflammatory bowel diseases 17 (4), 1008-1014, 2011
The Influence of Anti–tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease
IE Koutroubakis, C Ramos-Rivers, M Regueiro, E Koutroumpakis, B Click, ...
Inflammatory bowel diseases 21 (7), 1587-1593, 2015
Preventive therapy in postoperative Crohn's disease
JM Swoger, M Regueiro
Current opinion in gastroenterology 26 (4), 337-343, 2010
Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort.
IE Koutroubakis, C Ramos-Rivers, M Regueiro, E Koutroumpakis, B Click, ...
Journal of clinical gastroenterology, 2015
Tumor Necrosis Factor α Antagonist–associated Psoriasis in Inflammatory Diseases: An Analysis of the FDA Adverse Event Reporting System
KE Kip, JM Swoger, LM Grandinetti, AM Barrie III, JB Greer, MD Regueiro
Inflammatory bowel diseases 19 (6), 1164-1172, 2013
Evaluation for postoperative recurrence of Crohn disease
JM Swoger, M Regueiro
Gastroenterology clinics of North America 41 (2), 303-314, 2012
The system can't perform the operation now. Try again later.
Articles 1–20